Knockdown of FoxP3 in CCA cells in vitro reduced proliferation and invasiveness, inhibited T cell survival, and reduced IL10 and TGF-β signaling in the tumor microenvironment 78. This evidence concerns the gene FOXP3 and cholangiocarcinoma.